Incorporates an active component that will significantly shorten the treatment duration of MPE compared to current catheter devices.
A user-friendly design to promote patient independence, comfort and quality of life.
Reduces the costs associated with long-term home drainage and acute readmissions to hospital.
Posted in News by Nate Reynolds
19th July, 2023
SymPhysis Medical were thrilled to win the “Innovation of the Year” award at the Life Sciences Industry Awards which took place in Dublin on 7 July, 2023. Tim Jones and...
Read more
Posted in News by Nate Reynolds
14th June, 2023
In May 2023, SymPhysis Medical was delighted to be nominated for Innovation of the Year Award in the inaugural year of The Life Science Industry Awards for its first drainage...
Read more
Posted in News by Symphysis Medical
5th December, 2022
SymPhysis Medical were delighted to be nominated for the Emerging Medtech Company of the Year Award at the Irish Medtech Awards in December 2022. The Irish Medtech Association is the...
Read more
Posted in News by Symphysis Medical
24th November, 2022
The SymPhysis Medical team were delighted to win Best Indigenous Healthcare Start-up at the The HealthTech Innovation Awards in Dublin on 23 November. HealthTech Ireland is an independent trade association for...
Read more
Affects ~90% of patients with mesothelioma.
Affects ~ 35% of patients with lung cancer.
Affects ~ 16% of patients with breast cancer.
Affects ~ 11% of patients with lymphoma.
